# PATZ1

## Overview
PATZ1 is a gene that encodes the protein POZ/BTB and AT hook containing zinc finger 1, a transcription factor involved in various cellular processes. This protein is characterized by its modular structure, which includes a BTB/POZ domain, AT-hook motifs, and C2H2 zinc finger motifs, enabling it to participate in protein-protein interactions and DNA binding. As a transcription factor, PATZ1 plays a crucial role in regulating gene expression, influencing cell proliferation, differentiation, and apoptosis. It is particularly significant in embryogenesis and maintaining pluripotency in embryonic stem cells. The protein's ability to act as either a transcriptional activator or repressor is context-dependent, and it interacts with several other proteins, such as RNF4 and p53, to modulate its activity. PATZ1's involvement in various cancers, where it can function as both a tumor suppressor and an oncogene, underscores its importance in cellular regulation and its potential as a therapeutic target (Cho2011POZBTB; Valentino2013PATZ1; Fedele2017The).

## Structure
PATZ1 is a transcription factor characterized by a modular structure that includes several distinct domains. The protein contains a BTB/POZ domain at the N-terminus, which is involved in protein-protein interactions and dimerization, forming both homodimers and heterodimers with other BTB domain-containing proteins (Piepoli2020Structural; Fedele2017The). The BTB domain is highly conserved and features a unique glycine- and alanine-rich central loop in mammals, contributing to the modulation of the dimerization interface (Piepoli2020Structural).

The central region of PATZ1 includes one or two AT-hook motifs, which bind to AT-rich DNA sequences and are involved in chromatin remodeling and transcription regulation (Fedele2017The; Pero2012POZ). The C-terminus of the protein contains a cluster of classical C2H2 zinc finger motifs, which facilitate DNA binding, recognizing GC-rich sequences (Fedele2017The; Pero2012POZ).

PATZ1 exists in multiple splice variant isoforms, ranging from 537 to 687 amino acids, which influence its function and interactions (Fedele2017The; Pero2012POZ). These isoforms allow PATZ1 to act as either a transcriptional activator or repressor, depending on the cellular context (Fedele2017The). The protein's interactions with other factors, such as RNF4 and NCOR1, further modulate its transcriptional activity (Fedele2000A; Piepoli2020Structural).

## Function
PATZ1 is a transcription factor that plays a significant role in various molecular processes within healthy human cells. It is involved in regulating cell proliferation, differentiation, and apoptosis. PATZ1 functions as a transcriptional regulator, capable of acting as either an activator or repressor depending on the cellular context (Fedele2017The). It interacts with other proteins, such as RNF4 and Bach2, to influence gene transcription regulation and is involved in chromatin remodeling through its POZ/BTB and AT-hook domains (Fedele2017The).

In the nucleus, PATZ1 modulates the transcription of target genes, impacting processes like DNA damage response, senescence, and apoptosis (Fedele2017The). It is particularly active during embryogenesis, where it is highly expressed in the midbrain and associated with proliferating neuroblasts in the neocortical neuroepithelium (Fedele2017The). PATZ1 is essential for maintaining pluripotency in embryonic stem cells by regulating key pluripotency factors like Pou5f1 and Nanog (Fedele2017The).

PATZ1 also plays a role in endothelial cell senescence, where it inhibits senescence through a p53-dependent pathway, contributing to the regulation of cellular aging and vascular health (Cho2011POZBTB). Its expression is downregulated in older endothelial cells, correlating with increased markers of cellular senescence (Cho2011POZBTB).

## Clinical Significance
The PATZ1 gene plays a significant role in various cancers, acting as both a tumor suppressor and an oncogene depending on the context. In thyroid cancer, PATZ1 is downregulated, which is associated with the progression from differentiated to undifferentiated carcinomas. Restoration of PATZ1 expression in thyroid cancer cells can inhibit malignant behavior and promote partial re-differentiation, suggesting its tumor suppressor role (Monaco2018Loss; Fedele2017The). In non-small cell lung cancer (NSCLC), PATZ1 expression is heterogeneous, with high expression linked to better survival outcomes. It negatively correlates with PD-L1 expression, indicating a potential role in suppressing malignant phenotypes (Lucà2023PATZ1).

PATZ1 also interacts with the tumor suppressor protein p53, inhibiting its function and marking PATZ1 as a proto-oncogene in certain contexts. This interaction affects p53-dependent transcriptional activation, which is crucial for cell cycle regulation and apoptosis (Keskin2015PATZ1). In colorectal cancer, PATZ1 promotes cell growth by influencing the G1/S cell cycle transition and acts as a proto-oncogene by inhibiting p53 (Fedele2017The). These findings highlight the complex role of PATZ1 in cancer biology and its potential as a therapeutic target.

## Interactions
PATZ1, a transcription factor, engages in several significant protein-protein interactions that influence its role in gene regulation. It interacts with the human oncogene BCL6, forming a complex necessary for BCL6's negative autoregulation. This interaction is mediated through the POZ domain of PATZ1, and experiments have shown that PATZ1 and BCL6 bind to exon 1 of the BCL6 gene in vivo (Pero2012POZ). PATZ1 also interacts with the RNF4 RING finger protein, acting as a transcriptional repressor. This interaction occurs via the AT-hook DNA binding domain of PATZ1, and the two proteins colocalize in the nucleus, switching RNF4's activation to repression (Fedele2000A).

PATZ1 is part of protein complexes with the tumor suppressor p53, binding to promoters of p53-target genes such as BAX and CDKN1A. This interaction can enhance p53 transcriptional activity, promoting apoptosis or cell survival depending on the cellular context (Valentino2013PATZ1). Additionally, PATZ1 interacts with the regulatory subunit RIa of the cAMP-dependent protein kinase, affecting its subcellular localization and transcriptional activity (Yang2010Interaction). These interactions highlight PATZ1's versatile role in transcriptional regulation and its potential implications in oncogenesis.


## References


[1. (Fedele2000A) Monica Fedele, Giovanna Benvenuto, Raffaela Pero, Barbara Majello, Sabrina Battista, Francesca Lembo, Erminia Vollono, Patricia M. Day, Massimo Santoro, Luigi Lania, Carmelo Bruno Bruni, Alfredo Fusco, and Lorenzo Chiariotti. A novel member of the btb/poz family, patz, associates with the rnf4 ring finger protein and acts as a transcriptional repressor. Journal of Biological Chemistry, 275(11):7894–7901, March 2000. URL: http://dx.doi.org/10.1074/JBC.275.11.7894, doi:10.1074/jbc.275.11.7894. This article has 109 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.275.11.7894)

[2. (Fedele2017The) Monica Fedele, Elvira Crescenzi, and Laura Cerchia. The poz/btb and at-hook containing zinc finger 1 (patz1) transcription regulator: physiological functions and disease involvement. International Journal of Molecular Sciences, 18(12):2524, November 2017. URL: http://dx.doi.org/10.3390/ijms18122524, doi:10.3390/ijms18122524. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms18122524)

[3. (Lucà2023PATZ1) Stefano Lucà, Renato Franco, Antonella Napolitano, Valeria Soria, Andrea Ronchi, Federica Zito Marino, Carminia Maria Della Corte, Floriana Morgillo, Alfonso Fiorelli, Antonio Luciano, Giuseppe Palma, Claudio Arra, Sabrina Battista, Laura Cerchia, and Monica Fedele. Patz1 in non-small cell lung cancer: a new biomarker that negatively correlates with pd-l1 expression and suppresses the malignant phenotype. Cancers, 15(7):2190, April 2023. URL: http://dx.doi.org/10.3390/cancers15072190, doi:10.3390/cancers15072190. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15072190)

[4. (Valentino2013PATZ1) T Valentino, D Palmieri, M Vitiello, G M Pierantoni, A Fusco, and M Fedele. Patz1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context. Cell Death &amp; Disease, 4(12):e963–e963, December 2013. URL: http://dx.doi.org/10.1038/cddis.2013.500, doi:10.1038/cddis.2013.500. This article has 50 citations.](https://doi.org/10.1038/cddis.2013.500)

[5. (Piepoli2020Structural) Sofia Piepoli, Aaron Oliver Alt, Canan Atilgan, Erika Jazmin Mancini, and Batu Erman. Structural analysis of the patz1 btb domain homodimer. Acta Crystallographica Section D Structural Biology, 76(6):581–593, May 2020. URL: http://dx.doi.org/10.1107/s2059798320005355, doi:10.1107/s2059798320005355. This article has 5 citations.](https://doi.org/10.1107/s2059798320005355)

[6. (Monaco2018Loss) Mario Monaco, Giuseppe Palma, Michela Vitiello, Anna Capiluongo, Barbara D’Andrea, Emilia Vuttariello, Antonio Luciano, Laura Cerchia, Gennaro Chiappetta, Claudio Arra, Alfredo Fusco, and Monica Fedele. Loss of one or two patz1 alleles has a critical role in the progression of thyroid carcinomas induced by the ret/ptc1 oncogene. Cancers, 10(4):92, March 2018. URL: http://dx.doi.org/10.3390/cancers10040092, doi:10.3390/cancers10040092. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers10040092)

[7. (Keskin2015PATZ1) Nazli Keskin, Emre Deniz, Jitka Eryilmaz, Manolya Un, Tugce Batur, Tulin Ersahin, Rengul Cetin Atalay, Shinya Sakaguchi, Wilfried Ellmeier, and Batu Erman. Patz1 is a dna damage-responsive transcription factor that inhibits p53 function. Molecular and Cellular Biology, 35(10):1741–1753, May 2015. URL: http://dx.doi.org/10.1128/mcb.01475-14, doi:10.1128/mcb.01475-14. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01475-14)

[8. (Yang2010Interaction) Weng-Lang Yang, Roald Ravatn, Kazuya Kudoh, Leah Alabanza, and Khew-Voon Chin. Interaction of the regulatory subunit of the camp-dependent protein kinase with patz1 (znf278). Biochemical and Biophysical Research Communications, 391(3):1318–1323, January 2010. URL: http://dx.doi.org/10.1016/j.bbrc.2009.12.026, doi:10.1016/j.bbrc.2009.12.026. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2009.12.026)

[9. (Cho2011POZBTB) J H Cho, M J Kim, K J Kim, and J-R Kim. Poz/btb and at-hook-containing zinc finger protein 1 (patz1) inhibits endothelial cell senescence through a p53 dependent pathway. Cell Death &amp; Differentiation, 19(4):703–712, November 2011. URL: http://dx.doi.org/10.1038/cdd.2011.142, doi:10.1038/cdd.2011.142. This article has 51 citations.](https://doi.org/10.1038/cdd.2011.142)

[10. (Pero2012POZ) Raffaela Pero, Dario Palmieri, Tiziana Angrisano, Teresa Valentino, Antonella Federico, Renato Franco, Francesca Lembo, Andres J. Klein-Szanto, Luigi Del Vecchio, Donatella Montanaro, Simona Keller, Claudio Arra, Vasiliki Papadopoulou, Simon D. Wagner, Carlo M. Croce, Alfredo Fusco, Lorenzo Chiariotti, and Monica Fedele. Poz-, at-hook-, and zinc finger-containing protein (patz) interacts with human oncogene b cell lymphoma 6 (bcl6) and is required for its negative autoregulation. Journal of Biological Chemistry, 287(22):18308–18319, May 2012. URL: http://dx.doi.org/10.1074/jbc.M112.346270, doi:10.1074/jbc.m112.346270. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M112.346270)